These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17600281)

  • 1. Thymosin alpha 1 as an adjunct to influenza vaccination in the elderly: rationale and trial summaries.
    Ershler WB; Gravenstein S; Geloo ZS
    Ann N Y Acad Sci; 2007 Sep; 1112():375-84. PubMed ID: 17600281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review.
    Panatto D; Amicizia D; Lai PL; Camerini R; De Rosa A; Gasparini R
    J Prev Med Hyg; 2011 Sep; 52(3):111-5. PubMed ID: 22010537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza and aging: age-related changes and the effects of thymosin on the antibody response to influenza vaccine.
    Ershler WB; Moore AL; Socinski MA
    J Clin Immunol; 1984 Nov; 4(6):445-54. PubMed ID: 6334692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study.
    Gravenstein S; Duthie EH; Miller BA; Roecker E; Drinka P; Prathipati K; Ershler WB
    J Am Geriatr Soc; 1989 Jan; 37(1):1-8. PubMed ID: 2642497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience.
    Lang PO; Govind S; Mitchell WA; Siegrist CA; Aspinall R
    Ageing Res Rev; 2011 Jul; 10(3):389-95. PubMed ID: 20888439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin α1 continues to show promise as an enhancer for vaccine response.
    Tuthill C; Rios I; De Rosa A; Camerini R
    Ann N Y Acad Sci; 2012 Oct; 1270():21-7. PubMed ID: 23050813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccines provide diminished protection but are cost-saving in older adults.
    Deans GD; Stiver HG; McElhaney JE
    J Intern Med; 2010 Feb; 267(2):220-7. PubMed ID: 20175868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccination in the elderly: can efficacy be enhanced?
    Ershler WB
    Geriatrics; 1988 Sep; 43(9):79-83. PubMed ID: 3044929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.
    Vesikari T; Forstén A; Herbinger KH; Cioppa GD; Beygo J; Borkowski A; Groth N; Bennati M; von Sonnenburg F
    Vaccine; 2012 Feb; 30(7):1388-96. PubMed ID: 22192847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities.
    den Elzen WP; Vossen AC; Cools HJ; Westendorp RG; Kroes AC; Gussekloo J
    Vaccine; 2011 Jun; 29(29-30):4869-74. PubMed ID: 21497631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly.
    Trzonkowski P; Myśliwska J; Pawelec G; Myśliwski A
    Biogerontology; 2009 Feb; 10(1):83-94. PubMed ID: 18563620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
    Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
    Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
    Belshe RB; Frey SE; Graham IL; Anderson EL; Jackson LA; Spearman P; Edupuganti S; Mulligan MJ; Rouphael N; Winokur P; Dolor RJ; Woods CW; Walter EB; Chen WH; Turley C; Edwards KM; Creech CB; Hill H; Bellamy AR;
    JAMA; 2014 Oct; 312(14):1420-8. PubMed ID: 25291578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.
    Hatz C; von Sonnenburg F; Casula D; Lattanzi M; Leroux-Roels G
    Vaccine; 2012 May; 30(23):3470-7. PubMed ID: 22446638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults.
    McElhaney JE; Coler RN; Baldwin SL
    Expert Rev Vaccines; 2013 Jul; 12(7):759-66. PubMed ID: 23885821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for seasonal and pandemic influenza.
    Nichol KL; Treanor JJ
    J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.